Showing results (2691-2700 of 6,778) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|November 4, 2017
Improving Patient Involvement in the Drug Development Process: Case Study of Potential Applications from an Online Peer Support NetworkAmrutha Anand, Helen Jane Brandwood, Matt Jameson EvansClinical Therapeutics|December 18, 2017
Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI StudyKi-Chul Sung, Yong-Seog Oh, Dong-Hun Cha, et al.Clinical Therapeutics|September 19, 2017
Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical AntipsychoticsDominic Pilon, Neeta Tandon, Marie-Hélène Lafeuille, et al.Clinical Therapeutics|September 20, 2017
Use of Adult Sensory Panel to Study Individual Differences in the Palatability of a Pediatric HIV Treatment DrugJulie A Mennella, Phoebe S Mathew, Elizabeth D LowenthalClinical Therapeutics|September 20, 2017
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-oldsIra Gantz, Liubov Sokolova, Lokesh Jain, et al.Clinical Therapeutics|September 30, 2017
A Thorough QT/QTc Study of Clobazam in Healthy VolunteersDwain Tolbert, Judy Gordon, Stuart Harris, et al.Clinical Therapeutics|July 15, 2017
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn PatientsAnna Silva Machado, Maura S Oliveira, Cristina Sanches, et al.Clinical Therapeutics|January 1, 1985
Postoperative pain relief with pentazocine and acetaminophen: comparison with other analgesic combinations and placeboA PettiClinical Therapeutics|July 3, 2016
DNA Damage Repair and the Emerging Role of Poly(ADP-ribose) Polymerase Inhibition in Cancer TherapeuticsKaren Rabenau, Erin HofstatterClinical Therapeutics|January 1, 1987
Effect of a new H2-blocker, famotidine, in reflux esophagitis among severely handicapped childrenS Miyake, M Yamada, H Iwamoto, et al.Pageof 678